🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare full dose MDMA-assisted thera...
Status
Terminated
Location
Offices of Dr. Ingrid Pacey MBBS FRCP[C]
Start Date
2014-10-14
Trial ID
NCT01958593
Treatments Being Tested
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
Intervention aimed at increasing knowledge of the human papillomavirus in h...
Status
Completed
Location
School of Nursing Benemérita Universidad Autonoma de Puebla
Start Date
2021-12-01
Trial ID
NCT06920589
Safety, tolerability and efficacy of BI 655066 in male and female patients ...
Status
Completed
Location
1311.1.0007 Boehringer Ingelheim Investigational Site
Start Date
2012-04
Trial ID
NCT01577550
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
The purpose of this study is to investigate the safety and effectiveness of...
Status
Terminated
Location
Orange County Research Center
Start Date
2013-12
Trial ID
NCT02020616
Treatments Being Tested
This is a Phase I, single-center trial to assess the safety, tolerability, ...
Status
Recruiting
Location
Huashan Hospital, Fudan University
Start Date
2026-02-05
Trial ID
NCT07409922
Treatments Being Tested
The main objective is to test the effect of prolonged therapy (24 weeks) wi...
Status
Completed
Location
Philadelphia VA Medical Center
Start Date
2012-01
Trial ID
NCT01516346
Treatments Being Tested
The objective of this clinical study was to assess the safety, tolerability...
Status
Completed
Location
Covance CRU
Start Date
2008-03
Trial ID
NCT01306422
This study seeks to evaluate the safety and efficacy of brazikumab versus p...
Status
Terminated
Location
Research Site
Start Date
2018-12-07
Trial ID
NCT03759288
Treatments Being Tested